imipenem / cilastatin 250 MG Injection
- RxCUI
- 1726204
- RxNorm name
- imipenem / cilastatin 250 MG Injection
- Display name
- imipenem / cilastatin 250 MG Injection
- Full name
- imipenem / cilastatin 250 MG Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:28
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PRIMAXIN IV | IMIPENEM AND CILASTATIN SODIUM | Merck Sharp & Dohme LLC | f41d8abd-7792-4918-1b93-bd83ea01955e | 2024-07-05 | Warnings, Adverse reactions | 1726204 |
| Imipenem and Cilastatin | IMIPENEM AND CILASTATIN SODIUM | Fresenius Kabi USA, LLC | ce771566-c4f2-447e-944a-6b908925c90b | 2022-10-11 | Warnings, Adverse reactions | 1726204 |
| Imipenem and Cilastatin | IMIPENEM AND CILASTATIN SODIUM | Fresenius Kabi USA, LLC | 0a1dd9b9-ada1-4bff-9dcb-18961254e9e8 | 2022-10-10 | Warnings, Adverse reactions | 1726204 |
| Imipenem and Cilastatin | IMIPENEM AND CILASTATIN SODIUM | Fresenius Kabi USA, LLC | 6ab0ca9e-9a79-4cab-9f09-470eda06952e | 2022-10-06 | Warnings, Adverse reactions | 1726204 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| f41d8abd-7792-4918-1b93-bd83ea01955e | imipenem / cilastatin 250 MG Injection | PSN | 34 | These highlights do not include all the information needed to use PRIMAXIN safely and effectively. See full prescribing information for PRIMAXIN. PRIMAXIN® (imipenem and cilastatin) for Injection, for intravenous use Initial U.S. Approval: 1985 | 20240705 |
| f41d8abd-7792-4918-1b93-bd83ea01955e | imipenem 250 MG / cilastatin 250 MG Injection | SY | 34 | These highlights do not include all the information needed to use PRIMAXIN safely and effectively. See full prescribing information for PRIMAXIN. PRIMAXIN® (imipenem and cilastatin) for Injection, for intravenous use Initial U.S. Approval: 1985 | 20240705 |
| f41d8abd-7792-4918-1b93-bd83ea01955e | cilastatin (as cilastatin sodium) 250 MG / imipenem 250 MG Injection | SY | 34 | These highlights do not include all the information needed to use PRIMAXIN safely and effectively. See full prescribing information for PRIMAXIN. PRIMAXIN® (imipenem and cilastatin) for Injection, for intravenous use Initial U.S. Approval: 1985 | 20240705 |
| f41d8abd-7792-4918-1b93-bd83ea01955e | cilastatin 250 MG / imipenem 250 MG Injection | SCD | 34 | These highlights do not include all the information needed to use PRIMAXIN safely and effectively. See full prescribing information for PRIMAXIN. PRIMAXIN® (imipenem and cilastatin) for Injection, for intravenous use Initial U.S. Approval: 1985 | 20240705 |
| 6ab0ca9e-9a79-4cab-9f09-470eda06952e | imipenem / cilastatin 250 MG Injection | PSN | 12 | These highlights do not include all the information needed to use Imipenem and Cilastatin for Injection, USP (I.V.) safely and effectively. See full prescribing information for Imipenem and Cilastatin for Injection, USP (I.V.). IMIPENEM AND CILASTATIN FOR INJECTION, USP, for intravenous use Initial U.S. Approval: 1985 | 20221006 |
| 6ab0ca9e-9a79-4cab-9f09-470eda06952e | imipenem 250 MG / cilastatin 250 MG Injection | SY | 12 | These highlights do not include all the information needed to use Imipenem and Cilastatin for Injection, USP (I.V.) safely and effectively. See full prescribing information for Imipenem and Cilastatin for Injection, USP (I.V.). IMIPENEM AND CILASTATIN FOR INJECTION, USP, for intravenous use Initial U.S. Approval: 1985 | 20221006 |
| 6ab0ca9e-9a79-4cab-9f09-470eda06952e | cilastatin (as cilastatin sodium) 250 MG / imipenem 250 MG Injection | SY | 12 | These highlights do not include all the information needed to use Imipenem and Cilastatin for Injection, USP (I.V.) safely and effectively. See full prescribing information for Imipenem and Cilastatin for Injection, USP (I.V.). IMIPENEM AND CILASTATIN FOR INJECTION, USP, for intravenous use Initial U.S. Approval: 1985 | 20221006 |
| 6ab0ca9e-9a79-4cab-9f09-470eda06952e | cilastatin 250 MG / imipenem 250 MG Injection | SCD | 12 | These highlights do not include all the information needed to use Imipenem and Cilastatin for Injection, USP (I.V.) safely and effectively. See full prescribing information for Imipenem and Cilastatin for Injection, USP (I.V.). IMIPENEM AND CILASTATIN FOR INJECTION, USP, for intravenous use Initial U.S. Approval: 1985 | 20221006 |
| 0a1dd9b9-ada1-4bff-9dcb-18961254e9e8 | cilastatin (as cilastatin sodium) 250 MG / imipenem 250 MG Injection | SY | 7 | These highlights do not include all the information needed to use Imipenem and Cilastatin for Injection, USP (I.V.) safely and effectively. See full prescribing information for Imipenem and Cilastatin for Injection, USP (I.V.). IMIPENEM AND CILASTATIN FOR INJECTION, USP, for intravenous use Initial U.S. Approval: 1985 | 20221010 |
| 0a1dd9b9-ada1-4bff-9dcb-18961254e9e8 | imipenem / cilastatin 250 MG Injection | PSN | 7 | These highlights do not include all the information needed to use Imipenem and Cilastatin for Injection, USP (I.V.) safely and effectively. See full prescribing information for Imipenem and Cilastatin for Injection, USP (I.V.). IMIPENEM AND CILASTATIN FOR INJECTION, USP, for intravenous use Initial U.S. Approval: 1985 | 20221010 |
| 0a1dd9b9-ada1-4bff-9dcb-18961254e9e8 | cilastatin 250 MG / imipenem 250 MG Injection | SCD | 7 | These highlights do not include all the information needed to use Imipenem and Cilastatin for Injection, USP (I.V.) safely and effectively. See full prescribing information for Imipenem and Cilastatin for Injection, USP (I.V.). IMIPENEM AND CILASTATIN FOR INJECTION, USP, for intravenous use Initial U.S. Approval: 1985 | 20221010 |
| 0a1dd9b9-ada1-4bff-9dcb-18961254e9e8 | imipenem 250 MG / cilastatin 250 MG Injection | SY | 7 | These highlights do not include all the information needed to use Imipenem and Cilastatin for Injection, USP (I.V.) safely and effectively. See full prescribing information for Imipenem and Cilastatin for Injection, USP (I.V.). IMIPENEM AND CILASTATIN FOR INJECTION, USP, for intravenous use Initial U.S. Approval: 1985 | 20221010 |
| ce771566-c4f2-447e-944a-6b908925c90b | cilastatin (as cilastatin sodium) 250 MG / imipenem 250 MG Injection | SY | 5 | These highlights do not include all the information needed to use Imipenem and Cilastatin for Injection, USP (I.V.) safely and effectively. See full prescribing information for Imipenem and Cilastatin for Injection, USP (I.V.). IMIPENEM AND CILASTATIN FOR INJECTION, USP, for intravenous use Initial U.S. Approval: 1985 | 20221011 |
| ce771566-c4f2-447e-944a-6b908925c90b | imipenem 250 MG / cilastatin 250 MG Injection | SY | 5 | These highlights do not include all the information needed to use Imipenem and Cilastatin for Injection, USP (I.V.) safely and effectively. See full prescribing information for Imipenem and Cilastatin for Injection, USP (I.V.). IMIPENEM AND CILASTATIN FOR INJECTION, USP, for intravenous use Initial U.S. Approval: 1985 | 20221011 |
| ce771566-c4f2-447e-944a-6b908925c90b | imipenem / cilastatin 250 MG Injection | PSN | 5 | These highlights do not include all the information needed to use Imipenem and Cilastatin for Injection, USP (I.V.) safely and effectively. See full prescribing information for Imipenem and Cilastatin for Injection, USP (I.V.). IMIPENEM AND CILASTATIN FOR INJECTION, USP, for intravenous use Initial U.S. Approval: 1985 | 20221011 |
| ce771566-c4f2-447e-944a-6b908925c90b | cilastatin 250 MG / imipenem 250 MG Injection | SCD | 5 | These highlights do not include all the information needed to use Imipenem and Cilastatin for Injection, USP (I.V.) safely and effectively. See full prescribing information for Imipenem and Cilastatin for Injection, USP (I.V.). IMIPENEM AND CILASTATIN FOR INJECTION, USP, for intravenous use Initial U.S. Approval: 1985 | 20221011 |